Correlation Between Kamada and Enlivex Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kamada and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kamada and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kamada and Enlivex Therapeutics, you can compare the effects of market volatilities on Kamada and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kamada with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kamada and Enlivex Therapeutics.

Diversification Opportunities for Kamada and Enlivex Therapeutics

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Kamada and Enlivex is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Kamada and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Kamada is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kamada are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Kamada i.e., Kamada and Enlivex Therapeutics go up and down completely randomly.

Pair Corralation between Kamada and Enlivex Therapeutics

Assuming the 90 days trading horizon Kamada is expected to generate 0.39 times more return on investment than Enlivex Therapeutics. However, Kamada is 2.58 times less risky than Enlivex Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  155,000  in Kamada on September 1, 2024 and sell it today you would earn a total of  55,600  from holding Kamada or generate 35.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kamada  vs.  Enlivex Therapeutics

 Performance 
       Timeline  
Kamada 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Kamada are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Kamada is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Enlivex Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Kamada and Enlivex Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kamada and Enlivex Therapeutics

The main advantage of trading using opposite Kamada and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kamada position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.
The idea behind Kamada and Enlivex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements